Noticias financieras organizadas para conectar titulares, símbolos, fuente, fecha y sentimiento con tu análisis y operativa.
PAOG
Si escribes ticker, YENOM prioriza ese instrumento. Si lo dejas vacío puedes explorar el feed general o por tema.
seekingalpha.comPOSITIVO
PAO group appoints James Schramm as CEO
[CEO 3d rendering.jpg] naotake * PAO Group (OTCPK:PAOG [https://seekingalpha.com/symbol/PAOG]) has appointed [https://seekingalpha.com/pr/20231615-bed-bath-and-beyond-inc-completes-10-million-acquisition-of-kirkland-s-home-brand-assets] Ja…
Puration Inc. Dallas, Texas, April 20, 2022 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) today published a shareholder update from CEO Brian Shibley. The update is included in its entirety below: Dear Shareholders: The closing of 20…
PURA New Industrial Hemp Business Sees Revenue Traction
Puration Inc. Dallas, Texas, April 18, 2022 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) today announced the company has published its 2021 annual report. “2021 was a transition year for PURA,” said CEO Brian Shibley. “Our 2021 reve…
PURA Schedules Shareholder Update To Follow 2021 Annual Report
Puration Inc. Dallas, Texas, April 14, 2022 (GLOBE NEWSWIRE) -- Puration, Inc. (OTC Pink: PURA) today announced the company has scheduled a shareholder update to be published next week on Wednesday, April 20, 2022. The update will follow t…
PAOG Expects Increased Visibility For Its CBD Nutraceuticals From USMJ Ecommerce Campaign
Sandusky, OH, Feb. 03, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to enjoy increased market visibility for its RX Branded CBD Nutraceuticals resulting from the kickoff of the USMJ Ecommerc…
PAOG To Expand CBD Nutraceutical Sales In 2022 And Continue Pharmaceuticals Development
Sandusky, OH, Feb. 01, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today republished its 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy. The update was originally released on…
Sandusky, OH, Jan. 28, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today released a 2022 strategic update on the company’s CBD pharmaceutical and nutraceutical development strategy. The update is included in its entirety belo…
PAOG Cites Research On Hemp Compounds Effectiveness Treating Covid To Advance Pharmaceutical Development
Sandusky, OH, Jan. 25, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today cited recently published information on research indicating CBDA and CBGA, compounds found in hemp, “block a critical step in the process the [Covid] vi…
PAOG Confirms Farmersville Hemp Brand CBD Product Line Development For PURA
Sandusky, OH, Jan. 06, 2022 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed the development of a line of CBD nutraceutical products for Puration, Inc. (OTC Pink: PURA) is underway. PURA has updated its business model o…
UPDATE -- PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full spectrum CBD products are now available for sale at www.usmj.com. PAOG is developing both pharmaceutic…
PAOG Recommends Its RelaxRX Full Spectrum CBD To Ease Stress Before Fed Decision
Sandusky, OH, Dec. 15, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s line of “RX” branded full spectrum CBD products are now available for sale at www.usmj.com. PAOG is developing both pharmaceutic…
PAOG Acquisition To Expand CBD IP Portfolio Scheduled To Close December 3rd
Sandusky, OH, Nov. 24, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the acquisition of an exclusive license to patented cannabis extraction process that will expand the company’s existing CBD intellectual prope…
PAOG Announces Pending Acquisition To Expand CBD IP Portfolio Scheduled For Early December
Sandusky, OH, Nov. 19, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized terms for the acquisition of a license to a patented cannabis extraction process that will expand the company’s exis…
PAOG New Pharmaceutical Product Developments Could Generate Rapid Revenue Surge
Sandusky, OH, Nov. 17, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC PINK: PAOG) today confirmed plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmac…
PAOG Expects To Soon Launch 3rd CBD Nutraceutical Adding To 2021 Revenue Potential
Sandusky, OH, Nov. 09, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is on track to introduce yet a third CBD nutraceutical product by year end. PAOG recently announced the launch of its first two CB…
PAOG Adds Bioidentical Synthetic CBD To Research Pipeline
Sandusky, OH, Nov. 08, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company adding bioidentical synthetic CBD to its overall research initiative. PAOG management highlights the fact that CBD extracted from…
PAOG Announces Plans To Add New Pharmaceutical Product Developments
Sandusky, OH, Nov. 05, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced plans to add multiple new pharmaceutical products to its development pipeline in addition to its ongoing development of its RespRx CBD pharmac…
PAOG Announces CBD Pet Product Line To Launch In December
Sandusky, OH, Nov. 01, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has finalized plans to launch its CBD pet product line in December. The pet products market is estimated at over $100 billion per…
PAOG Entertains Partnership To Accelerate Development Of CBD Pharmaceutical Treatment For $14 Billion COPD Market
Sandusky, OH, Oct. 28, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company is entertaining a partnership opportunity to accelerate the ongoing development of its RespRx CBD pharmaceutical for the treatment…
PAOG Targets First Acquisition By Year End To Accelerate 2022 Revenue Growth
Sandusky, OH, Oct. 26, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company’s merger and acquisition development pipeline supports plans for a first acquisition to close before the end of this year. PAOG is…
PAOG Announces CBD “RX” Brand Introducing Second CBD Product
Sandusky, OH, Oct. 21, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its second CBD nutraceutical product, RehabRX CBD, in a line of coming CBD products under the PAOG CBD “RX” brand name. RehabRX…
PAOG Reveals CBD Products Under Development For $100 Billion Pet Market
Sandusky, OH, Oct. 20, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today revealed the company has been working on the development of CBD products for pets and could have its first product ready to introduce before the end of…
PAOG Scheduled To Launch 2nd CBD Nutraceutical Product This Thursday
Sandusky, OH, Oct. 19, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) yesterday announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical prod…
PAOG To Launch Second CBD Nutraceutical Product Later This Week Further Ramping Up 2021 Revenue Potential
Sandusky, OH, Oct. 18, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) earlier today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. The company plans to launch its second CBD nutraceutical…
PAOG Introduces RelaxRX CBD Targeting $100 Billion Sleep Aid
Sandusky, OH, Oct. 18, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the launch of its first CBD nutraceutical product, RelaxRX CBD, a sleep aid. RelaxRX is available in 30mg Softgels and in an 1800mg Tincture.…
PAOG Confirms Monday Marketing Launch Of First CBD Product Targeting $100 Billion Market
Sandusky, OH, Oct. 15, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today confirmed shipping its first CBD nutraceutical product to its distribution partner, North American Cannabis Holdings, Inc. (OTC Pink: USMJ). PAOG plans…
PAOG Announces Market Launch Of First CBD Nutraceutical To Take Place On Monday October 18th
Sandusky, OH, Oct. 14, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the market launch of its first CBD Nutraceutical is schedule to take place on Monday, October 18th, 2021. PAOG expects to realize its first CB…
PAOG CBD Pharmaceutical Respiratory Treatment Research Garners New Interest
Sandusky, OH, Oct. 13, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced encountering a flurry of outside interest of late into the company’s CBD pharmaceutical respiratory treatment research. Last year, the company…
PAOG Set To Realize First CBD Nutraceutical Sales In Q4 With Rapid Revenue Growth Expected To Follow
Sandusky, OH, Oct. 11, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company expects to realize its first CBD nutraceutical product sales beginning imminently in Q4, 2021. The company confirms shipping its f…
PAOG Ships First CBD Nutraceutical Product To Distributor Entering $16 Billion Market
Sandusky, OH, Oct. 07, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced shipping its first CBD nutraceutical product to its distribution partner. PAOG is developing CBD pharmaceutical and nutraceuticals from its in…
PAOG Targets Expansion And Accelerated Revenue Growth Through M&A To Complement Existing CBD Business
Sandusky, OH , Oct. 04, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC PINK: PAOG) today announced the company is actively exploring merger and acquisition opportunities targeted at expanding the company’s product line and accelerating reve…
PAOG On Track To Begin Generating Revenue This Year From CBD Nutraceutical Sales
Sandusky, OH , Sept. 30, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) today announced the company has initiated production on its first line of CBD nutraceuticals and is on track to generate its first revenue this year, in 202…
PAOG CBD Nutraceutical Launch Timed To Capture Market Momentum
Sandusky, OH, Sept. 29, 2021 (GLOBE NEWSWIRE) -- PAO Group, Inc. (OTC Pink: PAOG) has announced plans to soon launch a CBD nutraceuticals line of products expected to generate revenue this year, in 2021. Today the company highlights CBD in…
PAOG CBD RELAX-RX Co-Packing with ALKM And Marketing with USMJ Detailed In Update Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - March 9, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company's CBD RELAX-RX nutraceutical develop…
PAOG CBD RELAX-RX Co-Packing with ALKM And Marketing with USMJ Detailed In Update Scheduled Next Week
Sandusky, Ohio--(Newsfile Corp. - March 9, 2021) - PAO Group, Inc. (OTC Pink: PAOG) today announced an update scheduled one week from today, for Tuesday, March 16, 2021 to publish details on the company's CBD RELAX-RX nutraceutical develop…
PURA Farmersville Hemp Brand Positioned To Capitalize On President Biden's Environmental Initiative
Dallas, Texas--(Newsfile Corp. - February 12, 2021) - Puration, Inc. (OTC Pink: PURA) today announced publishing a multimedia presentation detailing the Company's plans to construct a 70-acre facility designed to provide interactive, demon…